The agreement grants the Japanese pharma the worldwide license to initially use Sangamo's proprietary neurotropic ...

Sometimes pain is a necessary warning signal; for example, if we touch something very hot and it burns, we know to move our ...

Astellas Pharma and Sangamo Therapeutics have signed a licence agreement for a neurotropic adeno-associated virus (AAV) ...

ELEVECTA™ producer cell line is a stable line for inducible AAV production. It is a true producer cell line that has Rep, Helper, Cap, and gene of interest (GOI) stably integrated into the host cell’s ...

The Vericheck ddPCR Empty-Full Capsid Kits comprise a capsid detection assay in FAM and an ITR-2 assay in HEX. The ITR-2 ...

Research led by Christian Medical College in Vellore, India, has demonstrated the successful use of lentiviral vectors to ...

Researchers are shining a light on cancer cells' energy centers—literally—to damage these power sources and trigger ...

(RTTNews) - Astellas Pharma Inc. (ALPMY) Thursday said it has signed an agreement with Sangamo Therapeutics, Inc. (SGMO) to leverage Sangamo's proprietary neurotropic adeno-associated virus (AAV) ...